Therapeutic Asset Ratings
394 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FLUDROCORTISONE
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLC
P3
B
(59)
FLUDROCORTISONE
Prostate Neoplasm
Merck Sharp & Dohme LLC
P3
B
(59)
LENVATINIB
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC
P3
B
(59)
Olaparib
Lung Neoplasm
Merck Sharp & Dohme LLC
P3
B
(59)
Opevesostat
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLC
P3
B
(59)
Opevesostat
Prostate Neoplasm
Merck Sharp & Dohme LLC
P3
B
(59)
Vibostolimab
Melanoma
Merck Sharp & Dohme LLC
P3
B
(59)
(+)-VINCRISTINE
Cervical Cancer
Merck Sharp & Dohme LLC
P3
B
(59)
Boserolimab
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC
P2
B
(59)
her3-dxd
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC
P2
B
(59)
Tocilizumab
B-Cell Acute Lymphoblastic Leukemia
Merck Sharp & Dohme LLC
P2/3
B
(59)
Lorazepam
Diffuse Large B-Cell Lymphoma
Merck Sharp & Dohme LLC
P3
B
(58)
Carboplatin
Cholangiocarcinoma
Merck Sharp & Dohme LLC
P2
B
(58)
Eloxatin
Ovarian Neoplasm
Merck Sharp & Dohme LLC
P2
B
(58)
Elpipodect
Schizophrenia
Merck Sharp & Dohme LLC
P2
B
(58)
FLUOROURACILUM
Ovarian Neoplasm
Merck Sharp & Dohme LLC
P2
B
(58)
mk-0482
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC
P2
B
(58)
mk-4830
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC
P2
B
(58)
Nemtabrutinib
Waldenstrom Macroglobulinemia
Merck Sharp & Dohme LLC
P2
B
(58)
Calcium folinate pentahydrate
Esophageal Cancer
Merck Sharp & Dohme LLC
P1/2
B
(58)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Gastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLC
P1/2
B
(58)
DEXAMETHASONE
Fallopian Tube Cancer
Merck Sharp & Dohme LLC
P3
B
(57)
Pembrolizumab/Vibostolimab Coformulation
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC
P3
B
(57)
Solu-Cortef
Prostate Neoplasm
Merck Sharp & Dohme LLC
P3
B
(57)
Capecitabine
Endometrial Cancer
Merck Sharp & Dohme LLC
P2
B
(57)
Showing 126 to 150 of 394 assets
Previous
Page 6 of 16
Next